The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease

Israel Medical Association Journal

Volumn 9, Issue 4, 2007, Pages 271-276

  Shechter, Michael ^a   Marai, Ibrahim ^a   Marai, Saed ^a   Sherer, Yaniv ^a   Sela, Ben Ami ^a   Feinberg, Micha S ^a   Rubinstein, Ardon ^b   Shoenfeld, Yehuda ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Atherosclerosis; Coronary artery disease; Endothelial function

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK ASSESSMENT; SMOKING; STROKE; VASODILATATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, PULSED; VASODILATION; VASODILATOR AGENTS;

EID: 34247868927     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002;39:257-65.
2. Vaudo G, Marchesi S, Gerli R, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004;63:31-5.
3. Sorensen KE, Celemajer DS, Spiegelhalter DJ, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-53.
4. Celemajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:111-15.
5. Shechter M, Sharir M, Labrador MJ, Forrester J, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000;102:2353-8.
6. Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels below 100 mg/dl. Am J Cardiol 2000;86:1256-9.
7. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis [Review]. Clin Cardiol 1997;20:426-32.
8. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991;84:1272-7.
9. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effects of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
10. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
11. Halcox JPJ, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8.
12. Shechter M, Matetzky S, Feinberg M, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol 2003;42:2090-5.
13. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for Quantification of Doppler Echocardiography: A Report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84.
14. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-74.
15. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-75.
16. Brunner H, Cockcroft JR, Deanfield I, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005;23:233-46.
17. Adams MR, Robinson J, McCredie R, et al. Smooth muscle dysfunction occurs independently of impaired endothelium dependent dilatation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32:123-7.
18. Lerman A, Burnett JC, Higano ST, McKinley LJ, Holmes DR Jr. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 1998;97:2123-8.
19. Wildansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implication of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-60.
20. Shechter M, Sherer Y. Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk? IMAJ 2003;5:736-8.
21. Lupattelli G, Marchesi S, Lombardini R, et al. Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia. Metabolism 2003;52:1191-5.
22. Tsen CM, Hsieh CC, Yen CH, Lau YT. Homocysteine altered ROS generation and NO accumulation in endothelial cells. Chin J Physiol 2003;46:129-36.
23. Gonzalez MA, Selwyn AP. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med 2003;115(Suppl 8A):99-106S.
24. Backes IM, Howard PA, Moriarty PM. Role of C-reactive protein in cardiovascular disease. Ann Pharmacother 2004;38:110-18.
25. Matz RL, Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 2003;20:527-50.